Galmed Pharmaceuticals Income Statement (2013-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)
Cost of Revenue (Quarter)				0.05M				0.20M
Operating items
Research & Development (Quarter)	7.04M	6.54M	6.26M	-0.17M	2.58M	4.24M	1.38M	1.08M	0.81M	0.56M	1.12M	0.64M	0.53M	0.74M	-1.76M	0.63M	1.06M	1.09M	-2.62M	1.36M
Selling, General & Administrative (Quarter)	1.38M	1.30M	1.23M	-0.03M	1.15M	1.14M	1.07M	0.92M	1.06M	0.91M	1.03M	0.77M	0.69M	1.27M	-2.21M	0.63M	1.05M	1.01M	-2.09M	0.68M
Other Operating Expenses (Quarter)	-0.02M	-0.13M		0.05M	0.00M	-0.03M		-0.17M	-0.28M	0.01M				-0.10M	5.61M				7.75M
Operating Expenses (Quarter)	8.41M	7.84M	7.49M	-0.25M	3.73M	5.38M	2.45M	2.00M	1.87M	1.47M	2.15M	1.40M	1.22M	2.01M	1.64M	1.26M	2.11M	2.10M	3.04M	2.04M
Operating Income (Quarter)					0.29M				0.57M				0.65M
EBIT (Quarter)		0.31M			0.29M	-0.03M			0.57M				0.65M
Non-operating items
Non Operating Investment Income (Quarter)	-0.03M	-0.01M				0.23M
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)	0.02M			-0.00M	-0.00M			0.01M	0.28M				0.10M	0.10M	-0.03M		0.14M	0.20M	-0.49M	-0.13M
Non Operating Income (Quarter)	-0.02M	-0.13M	-0.04M	0.05M				-0.17M	-0.28M	0.01M	0.47M	-0.13M	-0.10M	-0.10M	0.22M	-0.16M	-0.14M	-0.20M	0.46M	-0.13M
Net income details
EBT (Quarter)		0.18M			0.23M	-0.11M			0.47M				0.55M
Tax Provisions (Quarter)
Profit After Tax (Quarter)	8.40M	7.71M	-57.92M	-6.14M	3.73M	5.35M	-33.67M	-1.83M	1.59M	1.47M	-11.81M	-1.27M	1.12M	1.91M	-4.69M	1.10M	2.50M	1.89M	-5.81M	1.91M
Income from Non-Controlling Interests (Quarter)		183.00M		0.45M		-0.11M		-0.10M		-0.06M		0.00M				-0.02M				0.08M
Income from Continuing Operations (Quarter)		0.18M			0.23M	-0.11M			0.47M				0.55M
Consolidated Net Income (Quarter)		0.18M			0.23M	-0.11M			0.47M				0.55M
Income towards Parent Company (Quarter)		0.18M			0.23M	-0.11M			0.47M				0.55M
Net Income towards Common Stockholders (Quarter)		0.18M			0.23M	-0.11M			0.95				1.65				0.63
Additional items
EPS (Basic) (Quarter)		1.31			1.61	-0.76			0.00				0.00				0.00
EPS (Diluted) (Quarter)		1.31			1.61	-0.76			0.00				0.00				0.00
Shares Outstanding (Quarter)	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.23M	0.23M	0.52M	0.83M	0.93M	0.93M	3.95M	5.46M	4.31M	4.31M
Shares Outstanding (Diluted) (Quarter)	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.52M	0.23M	0.46M	0.52M	0.83M	0.93M	1.78M	3.95M	5.46M	4.31M	6.59M
Shares Outstanding (Entity) (Quarter)	191.00		187.00	191.00	191.00		192.00	192.00	192.00		317.00	687.00	720.00	0.00M	0.00M		0.01M	0.01M	0.01M
EBITDA (Quarter)		0.31M			0.29M	-0.03M			0.57M				0.65M
Interest Expenses (Quarter)	0.17M	0.13M	0.09M	0.08M	0.06M	0.07M	0.09M	0.06M	0.10M	0.00M	-0.16M	0.11M	0.11M	0.11M	0.29M	0.17M	0.20M	0.24M	-0.54M	0.28M
Tax Rate (Quarter)

Research Tools

Datasets

Plans

Developers

Galmed Pharmaceuticals GLMD Income Statement (2013-2026)

Research Tools

Datasets

Plans

Developers

Galmed Pharmaceuticals GLMD Income Statement (2013-2026)

Create an account

Sign In

Reset Password